International Journal of Drug Policy

Article	Citations
Tackling the overdose crisis: The role of safe supply	123
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	98
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	86
Safer opioid distribution in response to the COVID-19 pandemic	74
COVID-19 and the health of people who use drugs: What is and what could be?	70
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	70
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	69
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	66
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	64
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	64
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	63
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	58
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	56
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	56
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	54
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	50
Access to cannabidiol without a prescription: A cross-country comparison and analysis	49
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	47
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	46
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	46
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	45
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	44
COVID-19 - Enacting a ‘new normal’ for people who use drugs	44
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures	43
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	43

Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	43
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	43
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	43
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use	42
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	42
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	40
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	40
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	40
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	40
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	38
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	38
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	38
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	37
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	37
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies	36
The impact of cannabis legalization in Uruguay on adolescent cannabis use	35
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain	34
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	34
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	34
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada	33
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	33
The protective effect of trusted dealers against opioid overdose in the U.S.	33
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors	33
“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site	32
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking	32
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis	32
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use	31
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey	31
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C	31
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)	30
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	30
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic	30
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market	30
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada	30
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada	30
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia	30
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work	29
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France	29
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia	29
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey	29
Price and product variation in Washington's recreational cannabis market	29
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic	28
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective	28
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand	28
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects	28
The perfect storm: COVID-19, mass incarceration and the opioid epidemic	27
No “back to normal” after COVID-19 for our failed drug policies	27
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom	27
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky	27
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	27

Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland	27
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast	26
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants	26
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives	26
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima	25
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study	25
Digital chemsex support and care: The potential of just-in-time adaptive interventions	24
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets	24
The internet market for Kratom, an opioid alternative and variably legal recreational drug	24
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply	24
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples	24
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy	24
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media	24
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services	23
Preliminary findings of the impact of COVID-19 on drugs crypto markets	23
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research	23
Latent patterns of polysubstance use among people who use opioids: A systematic review	23
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions	23
The impact of rurality on opioid-related harms: A systematic review of qualitative research	23
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19	22
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling	22
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options	22
Uncertainty and risk: A framework for understanding pricing in online drug markets	22
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada	22
Unity in diversity: A systematic review on the GHB using population	22
Peer-delivered services for substance use in low- and middle-income countries: A systematic review	22
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington	22
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence	22
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	22
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting	21
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations	21
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs	21
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures	21
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia	21
Alcohol policy has saved lives in the Russian Federation	21
Between gang talk and prohibition: The transfer of blame for County Lines	21
Good Samaritan laws and overdose mortality in the United States in the fentanyl era	21
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug	21
Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking	21
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	21
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK	21
Legal cannabis market shares during Canada's first year of recreational legalisation	20
The effectiveness of drug-related Good Samaritan laws: A review of the literature	20
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons	20
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review	20
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks	20
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination	20
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction	20
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity	20
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers	20
Alcohol and drinking within the lives of midlife women: A meta-study systematic review	20
Producing the vulnerable subject in English drug policy	20
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	19
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services	19
Youth drinking in decline: What are the implications for public health, public policy and public debate?	19
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles	19
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin	19
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs	19
Intensity of cannabis use: Findings from three online surveys	19
Individual and network factors associated with HCV treatment uptake among people who inject drugs	19
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care	19
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar	19
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?	19
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan	19
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	19
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria	19
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions	19
A systematic review of cigarette smoking trajectories in adolescents	18
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	18
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore	18
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months	18
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy	18
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics	18
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada	18
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care	18
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.	18
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	18
How to think with models and targets: Hepatitis C elimination as a numbering performance	18
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot	18
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada	17

Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust	17
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England	17
Sources of cannabis among young adults and associations with cannabis-related outcomes	17
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation	17
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-	17
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown	17
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing	17
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex	17
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	17
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage	17
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	17
Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex	17
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island	17
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts	17
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia	17
Pharmacosex: Reimagining sex, drugs and enhancement	17
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs	17
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland	16
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	16
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD	16
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada	16
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic	16
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)	16
Carfentanil on the darknet: Potential scam or alarming public health threat?	16
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C	16
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis	16
Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States	16
Testing the boundaries: Self-medicated testosterone replacement and why it is practised	16
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina	16
Public support for alcohol control initiatives across seven countries	16
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic	16
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	16
What explains the decline in adolescent binge-drinking in New Zealand?	16
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions	16
Growing pains: An overview of cannabis quality control and quality assurance in Canada	16
Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center	16
A qualitative study of a publicly funded pharmacy-dispensed naloxone program	16
Connections built and broken: The ontologies of relapse	16
Investigating opioid preference to inform safe supply services: A cross sectional study	16
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment	15
Young women’s narratives on sex in the context of heavy alcohol use: Friendships, gender norms and the sociality of consent	15
Rethinking enhancement substance use: A critical discourse studies approach	15
Effects of messaging on public support for drug consumption rooms in scotland, UK	15
Beyond the narco frontier; rethinking an imaginary of the margins	15
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia	15
Medicinal cannabis and driving: the intersection of health and road safety policy	15
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	15
Structural competency in the post-prison period for people who inject drugs: A qualitative case study	15
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia	15
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis	15
How medical are states’ medical cannabis policies?: Proposing a standardized scale	15
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	15
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway	15
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities	15
Hospital policy as a harm reduction intervention for people who use drugs	15
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting	15
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic	15
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms	15
The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions	15
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study	15
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort	15
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study	15
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders	14
The impact of alcohol taxation changes on unrecorded alcohol consumption: A review and recommendations	14
“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison	14
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts	14
Analytical findings in used syringes from a syringe exchange program	14
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England	14
Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors	14
Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts	14
The success rate of online illicit drug transactions during a global pandemic	14
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people	14
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020	14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy	14
#studydrugs–Persuasive posting on Instagram	14
Fentanyl epidemic hits the U.S. West Coast: Opioid-related deaths in San Francisco from 2009–2019	14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons	14
Co-creating a social science research agenda for clean sport: An international Delphi study	14
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	14
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation	14
Increasingly powerful opioid antagonists are not necessary	13
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island	13
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.	13
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy	13
Making sense of ‘‘drink responsibly’’ messages: Explorations of the understanding and interpretations of young Nigerians who use alcohol	13
“You need to just provide health services:” navigating the politics of harm reduction in the twin housing and overdose crises in Vancouver, BC	13
The effect of injecting alone on the use of drug checking services among people who inject drugs	13
A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services	13
Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada	13
A normalised future of addiction	13
Diverting people who use drugs from the criminal justice system: A systematic review of police-based diversion measures	13
Critical realism and the ‘ontological politics of drug policy’	13
Towards an ontological politics of drug policy: Intervening through policy, evidence and method	13
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand	13
Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”	13